30.8.2023

Biovian – Manufacturing facility project

We acted as advisor to Biovian in a EUR 50 million manufacturing facility project in Turku, Finland. The new facility to be constructed in connection with the project will cover an area of 6,400 sqm and house cutting-edge equipment and advanced technologies to support the development, manufacturing, and testing of ATMP (Advanced Therapy Medicinal Products). It will also feature dedicated Class A to D cleanroom areas for bulk drug substances as well as final drug product manufacture. The construction project is expected to be completed in December 2024.

Biovian is a globally operating GMP (Good Manufacturing Practice) contract development and manufacturing organisation (CDMO) of biopharmaceuticals, providing development and manufacturing services from early stage to finished product. Biovian is especially focusing on viral vector production, microbial production of recombinant proteins and GMP plasmid DNA.

Latest references

We are acting as the lead counsel to Fortum in a cross-border transaction in which Fortum is selling its recycling and waste business. The business is sold to thematic impact investing firm Summa Equity through its portfolio company NG Group. The debt-free purchase price is approximately EUR 800 million. The transaction is subject to authority approval and customary closing conditions. Fortum’s recycling and waste business to be sold comprises municipal and industrial waste management and end-to-end plastics, metals, ash, slag and hazardous waste treatment and recycling services. These businesses are located in Finland, Sweden, Denmark and Norway and currently employ approximately 900 employees.
Case published 18.7.2024
We assisted eQ Community Properties Fund in the sale of three healthcare and hospital properties to Niam. The properties have a total floor area of approximately 18,000 square meters. Two of the properties are located in Helsinki and one in Pori. Saukonpaadenranta 2 is a property in the maritime district of Jätkäsaari, with the private cancer hospital Docrates as its main tenant. Bulevardi 22 is a historical property where Mehiläinen, one of Finland’s largest private healthcare service providers, operates as the main tenant. The property in Pori, located in the heart of the city, has a lettable area of approximately 5,800 square metres and it is BREEAM Very Good certified. The property is fully leased to Terveystalo. 
Case published 5.7.2024
We advised funds managed by OP in a transaction whereby they sold two modern logistics properties to Logian. Logian is a joint venture between Keva and Mrec Investment Management Oy. The properties are located in Tuusula close to the Helsinki Airport, and their area is approximately 32,300 square metres in total. The properties hold the LEED Gold certificate with energy class A and feature solar panels that generate a significant share of the electricity used by the properties annually. 
Case published 3.7.2024
We advised OP-Rental Yield non-UCITS fund in the sale of two apartment buildings to Sirius Capital Partners. The object of sale comprised 158 apartments with the combined area of approximately 7,100 square metres. The buildings are located in Pasila and Etelä-Haaga in Helsinki. The building in Etelä-Haaga is very energy efficient with an EPC rating A, equipped with both solar panels  and geothermal heating. Sirius will be installing solar panels on the roof of the Pasila building, transforming its EPC rating from B to A.
Case published 24.6.2024